Loading...

DNA GINKGO BIOWORKS HOLDINGS INC Management Changes 8-K Filing

GNKG

DN

GINKGO BIOWORKS HOLDINGS INC

(DNA)

2025 8-K

Q3 Financial Results

Sales Agreement Signed

Settlement Announcement

Financial Statements

Financial Statements

Financial Results

Management Changes

Stock Split Approval

Results of Operations and F...

Restructuring Plan and Head...

Annual Meeting of Shareholders

Delisting Notice

Financial Results and Restr...

Changes in Registrant s Cer...

Earnings Reports

Earnings Reports

Earnings Reports

Bylaws Amendment

Bankruptcy or insolvency

Acquisition and Financial U...

Financial Results Announcement

Annual Meeting of Shareholders

Financial Results Announcement

Resignation and Appointment

Disclosure of Bank Closure

Financial Results Announcement

Acquisition of Zymergen Inc.

Earnings Reports

External Links:

Ginkgo Bioworks Holdings, Inc. announced the resignation of Chief Financial Officer Mark Dmytruk on May 19, 2025, effective May 30, 2025, with Steven Coen stepping in as the new CFO, earning $460,000 annually and receiving a performance-based stock award of 67,991 shares. The announcement was made official on May 21, 2025.

AI Assistant

GINKGO BIOWORKS HOLDINGS INC

2025

8 K

Find Answers

Ask about any part of the document to get insights, explanations, or key details.